Nh aeroflex.qxd

RoHS CS19-1 CS19-2 CS19-3
CS19-4 CS19-5 CS19-6 CS19-7
Silicon Diode with Glass Passivation
in a Epoxy Encapsulated Ceramic Package

Product Environmental Data Sheet
Note: Actual part maydiffer in shape and sizefrom depicted image.
(For visual purpose only) CS19-1 / CS19-2 / CS19-3 / CS19-4 / CS19-5 / CS19-6 / CS19-7
Component
Semiconductor Silicon Chip – Glass Passivated
Lead Glass – Acceptable per RoHS Annex 7c-1 (Lead in Glass) CS19-1 / CS19-2 / CS19-3 / CS19-4 / CS19-5 / CS19-6 / CS19-7
Component
Lid - Epoxy
CS19-1 / CS19-2 / CS19-3 / CS19-4 / CS19-5 / CS19-6 / CS19-7
Component
Package - Ceramic
Document No. DS 15184 Rev.B, ECN 13019 Revision Date: 7/9/2013 RoHS CS19-1 CS19-2 CS19-3
CS19-4 CS19-5 CS19-6 CS19-7
CS19-1 / CS19-2 / CS19-3 / CS19-4 / CS19-5 / CS19-6 / CS19-7
Component
Gold Wire
CS19-1 / CS19-2 / CS19-3 / CS19-4 / CS19-5 / CS19-6 / CS19-7
Component
Die Attach Preform
CS19-1 / CS19-2 / CS19-3 / CS19-4 / CS19-5 / CS19-6 / CS19-7
Component
Marking Ink
Cyclohexane – 1, 2 – dicarboxylic anhydride If the total % is less than 100% , the balance is not considered hazardous per OSHA Hazard CommunicationStandard ( 29 CFR 1910.1200) TOTAL (CS19-1)
TOTAL (CS19-2)
TOTAL (CS19-3)
TOTAL (CS19-4)
TOTAL (CS19-5)
TOTAL (CS19-6)
TOTAL (CS19-7)
603-641-3800 • 888-641-SEMI (7364) • [email protected] • www.aeroflex.com/metelics RoHS CS19-1 CS19-2 CS19-3
CS19-4 CS19-5 CS19-6 CS19-7
These parts are RoHS Compliant
The products designed by Aeroflex / Metelics as Lead (Pb) – free conform to the requirements for all substancesidentified in the Europeans Unions’ Restrictions on use of Hazardous Substances in Electrical and ElectronicEquipment (RoHS) Directive 2002/95/EC including Lead. Maximum limit does not apply to applicationscovered by the RoHS exemption. Note: Per European Directive RoHS 202/95/EC Annex 7c-1 the use of lead inglass or ceramic other than dielectric ceramic in capacitors (piezoelectronic devices) or in a glass or ceramicmatrix compound are exempt. All values can vary by +/- 20%. The information presented in this document isbelieved to be accurate, reliable and is a result of review of numerous sources including vendor submitteddatasheets. Data is the most current available to Metelics at the time of preparation and is issued as a matterof reference only. No warranty as to accuracy or completeness is expressed or implied. The information onthis document is subject to change without notice. All percentages are calculated from mass data declared.
When CAS is unavailable, vendor supplied comments such as “’Proprietary” or “Trade Secret” will bedocumented.
ISO 9001:2008 certified companies
54 Grenier Field Road, Londonderry, NH 03053Tel: (603) 641-3800Sales: (888) 641-SEMI (7364)Fax: (603)-641-3500 975 Stewart Drive, Sunnyvale, CA 94085Tel: (408) 737-8181Fax: (408) 733-7645 Aeroflex / Metelics, Inc. reserves the right to make changes to any products andservices herein at any time without notice. Consult Aeroflex or an authorized salesrepresentative to verify that the information in this data sheet is current beforeusing this product. Aeroflex does not assume any responsibility or liability arisingout of the application or use of any product or service described herein, exceptas expressly agreed to in writing by Aeroflex; nor does the purchase, lease, or useof a product or service from Aeroflex convey a license under any patent rights, Our passion for performance is defined by three copyrights, trademark rights, or any other of the intellectual rights of Aeroflex or attributes represented by these three icons: solution-minded, performance-driven and customer-focused.
Copyright 2012 Aeroflex / Metelics. All rights reserved.

Source: http://www.testmyradio.cn/AMS/Metelics/pdfiles/MD-CS19-1_thru_CS19-7.pdf

cran.um.ac.ir

Title Incremental Cost-Effectiveness (ICE) Statistical Inference from Two Unbiased SamplesAuthor Bob Obenchain <[email protected]>Maintainer Bob Obenchain <[email protected]>Description Given two unbiased samples of patient level data on costand effectiveness for a pair of treatments, make head-to-headtreatment comparisons by (i) generating the bivariate bootstrapresampling distribution

Coordinatie--ziv--kb-17-10-2005--tegemoetkoming-in-de-taba…

Coordinatie--ZIV--KB-17-10-2005--tegemoetkoming-in-de-tabaksontwenning--bij-zwangere-vrouwen-en-hun-partner.doc 17 SEPTEMBER 2005. - Koninklijk besluit tot vaststelling van de voorwaarden van de tegemoetkoming van de verplichte verzekering voor geneeskundige verzorging en uitkeringen in de tabaksontwenning bij zwangere vrouwen en hun partner Artikel 1. § 1. De tegemoetkomi

© 2008-2018 Medical News